TITLE

Acquisitions

PUB. DATE
July 2008
SOURCE
Cardiovascular Devices & Drugs;Jul2008, Vol. 14 Issue 7, p21
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article offers information on acquisitions within the medical device industry in the U.S. as of July 2008. Norwalk, Connecticut-based Applera has been separated from its diagnostic business Celera. Wayne, Pennsylvania-based Drew Scientific has purchased Miami, Florida-based JAS Diagnostics for about $1.2 million in cash and $800,000 in notes payable. Rochester, Minnesota-based Kardia Health Systems intends to expand its cardiology platforms as it acquires multi-modality medical imaging and reporting software solutions provider Freeland Systems.
ACCESSION #
33516934

 

Related Articles

  • Deals roundup.  // Diagnostics & Imaging Week;6/12/2008, Vol. 11 Issue 24, p13 

    The article reports on the acquisition of JAS Diagnostics based in Miami, Florida, by Drew Scientific, a wholly owned subsidiary of Escalon Medical of Wayne, Pennsylvania. In the acquisition deal, it is said that Drew bought 100% of the outstanding shares of JAS for about $1.2 million in cash...

  • Deals roundup.  // Diagnostics & Imaging Week;9/27/2007, Vol. 10 Issue 39, p8 

    The article reports that Celera, a business of Applera, has agreed to acquire Atria Genetics for about $33 million in cash. The company expects that the acquisition will be accretive to its earnings in the second half of fiscal year 2008, excluding the impact of acquisition-related intangible...

  • Kardia Expands Offerings. Sanchez, Elaine // Imaging Economics;Aug2008, Vol. 21 Issue 8, p17 

    The article reports on the acquisition of Freeland Systems by Kardia Health Systems Inc. in the U.S. According to the author, the purchase of Freeland is part of the company's strategy to provide complete web-based clinical, diagnostic and reporting software solutions to all its clients. Kardia...

  • Deals/Acquisitions.  // Biomedical Business & Technology;Oct2007, Vol. 30 Issue 10, p22 

    This section offers news briefs on deals and acquisitions in the biomedical business. Medical Device Partners has bought the Vermed unit of CardioDynamics International. Berkeley Heart Lab will be acquired by Celera, a unit of Applera, for $195 million in cash. DaVita has purchased 85% of the...

  • Deals roundup.  // Diagnostics & Imaging Week;6/12/2008, Vol. 11 Issue 24, p7 

    The article reports on the acquisition of the company Freeland Systems by Kardia Health Systems in the U.S. Freeland Systems offers multi-modality medical imaging and reporting software products. Kardia claimed that the deal will provide it with a more comprehensive line of high-performance...

  • Wright in asset acquisition; Kardia buys Freeland Systems.  // Medical Device Daily;6/11/2008, Vol. 12 Issue 112, p2 

    The article reports on merger deals involving medical technology companies. Wright Medical Group acquired some assets of A.M. Surgical, a company that specializes on endoscopic soft-tissue-release products for foot and ankle surgery. In an effort to expand its cardiology platforms, Kardia Health...

  • Deals roundup.  // Medical Device Daily;5/19/2011, Vol. 15 Issue 97, p8 

    The article announces that the acquisition of Quest Diagnostics to Celera was completed through a short-form merger under the Delaware law.

  • Beckman Coulter to buy Biosite in $1.55B deal.  // Medical Technology & Devices Week;4/2/2007, Vol. 5 Issue 14, p3 

    The article reports on the purchase by Beckman Coulter, a developer of products that automate complex biomedical tests, of biomedical company Biosite. Under the definitive merger agreement Beckman Coulter will acquire all of Biosite's outstanding common stock in a cash tender offer of $85 a...

  • Inverness reports no response to its higher offer for Biosite.  // Medical Device Daily;4/10/2007, Vol. 11 Issue 68, p9 

    The article reports on the efforts of medical device firm Inverness Medical Innovations (IMI) to acquire Biosite. IMI made an offer to buy Biosite at $90 per share, compared to $85 per share offered by rival bidder Beckman Coulter. Ron Zwanziger, president and chairman of IMI, is disappointed by...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics